Nationwide analysis of neuromyelitis optica in systemic lupus erythematosus and Sjogren's syndrome.
Faria SamiShahzad Ahmed SamiAugustine M ManadanShilpa AroraPublished in: Clinical rheumatology (2023)
NMO patients had a 12-fold higher risk of SLE and 5-fold higher risk of Sjogren's disease when compared to general population. Patients with overlap of NMO and SLE or Sjogren's were predominantly women and were more likely to be African-American. Co-existence of these autoimmune disorders was associated with poor prognosis in terms of higher morbidity for patients and increased health care burden. Key Points • NMO is a rare autoimmune disease seen predominantly in women in the middle age group with low overall mortality. • SLE and Sjogren's have increased odds of NMO in comparison to general population. • NMO patients have high rates of several complications such as paraplegia, quadriplegia, seizures, blindness, sepsis, and respiratory failure with even higher rates of seizures and paraplegia in those with concomitant SLE or Sjogren's.
Keyphrases
- end stage renal disease
- systemic lupus erythematosus
- poor prognosis
- ejection fraction
- african american
- newly diagnosed
- healthcare
- chronic kidney disease
- prognostic factors
- multiple sclerosis
- risk factors
- rheumatoid arthritis
- disease activity
- respiratory failure
- adipose tissue
- cardiovascular disease
- long non coding rna
- metabolic syndrome
- cross sectional
- health insurance
- drug induced
- health information
- insulin resistance
- septic shock